BCL2 and cancer: Tumor suppressive miRNAs mediate the degradation or post-transcriptional inhibition of transcripts encoding oncogenes and can target ZEB1/2, HMGB2, Bcl2 and HIF-1α, which contribute to the increased proliferation, invasion, and EMT and reduce the apoptosis of cancer cells.